Effect of recombinant human endostatin and lobaplatin peritoneal perfusion combined with radio-frequency hyperthermia on level of vascular endothelial growth factor and quality of life in patients with malignant hydroperitoneum[J]. Journal of Clinical Medicine in Practice, 2016, (5): 53-56. DOI: 10.7619/jcmp.201605016
Citation:
|
Effect of recombinant human endostatin and lobaplatin peritoneal perfusion combined with radio-frequency hyperthermia on level of vascular endothelial growth factor and quality of life in patients with malignant hydroperitoneum[J]. Journal of Clinical Medicine in Practice, 2016, (5): 53-56. DOI: 10.7619/jcmp.201605016
|
Effect of recombinant human endostatin and lobaplatin peritoneal perfusion combined with radio-frequency hyperthermia on level of vascular endothelial growth factor and quality of life in patients with malignant hydroperitoneum[J]. Journal of Clinical Medicine in Practice, 2016, (5): 53-56. DOI: 10.7619/jcmp.201605016
Citation:
|
Effect of recombinant human endostatin and lobaplatin peritoneal perfusion combined with radio-frequency hyperthermia on level of vascular endothelial growth factor and quality of life in patients with malignant hydroperitoneum[J]. Journal of Clinical Medicine in Practice, 2016, (5): 53-56. DOI: 10.7619/jcmp.201605016
|